These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

259 related items for PubMed ID: 23526600

  • 1. Use of rifabutin for the treatment of a latent tuberculosis infection in a patient after solid organ transplantation.
    Hickey MD, Quan DJ, Chin-Hong PV, Roberts JP.
    Liver Transpl; 2013 Apr; 19(4):457-61. PubMed ID: 23526600
    [Abstract] [Full Text] [Related]

  • 2. Treatment of tuberculosis with rifabutin in a renal transplant recipient.
    López-Montes A, Gallego E, López E, Pérez J, Lorenzo I, Llamas F, Serrano A, Andrés E, Illescas L, Gómez C.
    Am J Kidney Dis; 2004 Oct; 44(4):e59-63. PubMed ID: 15384035
    [Abstract] [Full Text] [Related]

  • 3. Experience of tacrolimus-based immunosuppression in living-related liver transplantation complicated with graft tuberculosis: interaction with rifampicin and side effects.
    Kiuchi T, Tanaka K, Inomata Y, Uemoto S, Satomura K, Egawa H, Uyama S, Sano K, Okajima H, Yamaoka Y.
    Transplant Proc; 1996 Dec; 28(6):3171-2. PubMed ID: 8962229
    [No Abstract] [Full Text] [Related]

  • 4. Tacrolimus as a risk factor for tuberculosis and outcome of treatment with rifampicin in solid organ transplant recipients.
    Ha YE, Joo EJ, Park SY, Wi YM, Kang CI, Chung DR, Joh JW, Lee SK, Song JH, Peck KR.
    Transpl Infect Dis; 2012 Dec; 14(6):626-34. PubMed ID: 22372581
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Outcome of latent tuberculosis infection in solid organ transplant recipients over a 10-year period.
    Sidhu A, Verma G, Humar A, Kumar D.
    Transplantation; 2014 Sep 27; 98(6):671-5. PubMed ID: 24825525
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Three months of weekly rifapentine plus isoniazid for latent tuberculosis treatment in solid organ transplant candidates.
    Knoll BM, Nog R, Wu Y, Dhand A.
    Infection; 2017 Jun 27; 45(3):335-339. PubMed ID: 28276008
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Experience with rifabutin replacing rifampin in the treatment of tuberculosis.
    Horne DJ, Spitters C, Narita M.
    Int J Tuberc Lung Dis; 2011 Nov 27; 15(11):1485-9, i. PubMed ID: 22008761
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The interaction between antiretroviral agents and tacrolimus in liver and kidney transplant patients.
    Jain AK, Venkataramanan R, Shapiro R, Scantlebury VP, Potdar S, Bonham CA, Ragni M, Fung JJ.
    Liver Transpl; 2002 Sep 27; 8(9):841-5. PubMed ID: 12200788
    [Abstract] [Full Text] [Related]

  • 18. Use of rifabutin in the treatment of pulmonary tuberculosis.
    Grassi C, Peona V.
    Clin Infect Dis; 1996 Apr 27; 22 Suppl 1():S50-4. PubMed ID: 8785257
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Mycobacterium tuberculosis infection in liver transplantation.
    Yehia BR, Blumberg EA.
    Liver Transpl; 2010 Oct 27; 16(10):1129-35. PubMed ID: 20879011
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.